Form EFFECT CRESCENT BIOPHARMA, INC.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 31, 2026 |
| Accession Number: | 0001628280-26-050885 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FT Portfolios Canada Co. Announces Cash Distributions for Its Exchange Traded Funds
- Ivalua Named a Leader in the IDC MarketScape: Worldwide AI-Enabled Direct Spend
- NATIONAL ROAD SAFETY FOUNDATION AND CHICAGO AUTO SHOW INVITE TEENS TO CREATE SCRIPT FOR TV PUBLIC SERVICE MESSAGE ABOUT DANGERS OF SPEEDING
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share